Your trusted destination for CME, CPD & Medical Education across the Middle East.
Mammoth Biosciences
Lucas Harrington is a scientist and biotechnology entrepreneur specializing in CRISPR gene-editing technologies. He is best known as a co-founder of Mammoth Biosciences, which he established alongside Jennifer Doudna and other colleagues, and as the founder and CEO of Preventive PBC, a company researching the potential use of gene editing to prevent inherited genetic diseases.
Harrington earned a Bachelor of Science in Chemistry from Washington University in St. Louis, where he conducted research on bacterial photosynthesis. He subsequently completed his doctoral studies at the University of California, Berkeley, working in the laboratory of CRISPR pioneer Jennifer Doudna.
During his research at Berkeley, Harrington focused on microbial diversity and the discovery of new CRISPR systems. His work contributed to the identification of Cas14, a compact CRISPR-associated protein system with potential applications in DNA detection and genome editing. This research was published in the scientific journal Science.
He went on to co-found Mammoth Biosciences, where he served as Chief Scientific Officer and helped lead the company's scientific research and development. Mammoth focuses on developing next-generation CRISPR technologies, including compact gene-editing systems and molecular diagnostic applications.
In 2025, Harrington founded Preventive PBC, a public benefit corporation dedicated to investigating whether emerging gene-editing technologies can safely and responsibly address severe genetic conditions before birth. The company's focus includes preclinical safety research and evaluating the scientific and ethical considerations of potential future clinical applications.

dmg events
dmg events